GeniPhys secures $6 million in Series A funding

GeniPhys, a company founded by Purdue University biomedical engineering professor Sherry Harbin, has raised a $6 million Series A round. The funding will support the launch of the company’s initial product into the market, expand its team, and invest in manufacturing and regulatory capabilities.

GeniPhys has developed a polymerizable collagen called Collymer, which can be designed and fabricated into materials with a variety of shapes, architectures and mechanical properties. It addresses unmet needs in markets like wound management, surgical reconstruction, orthopedics, cardiovascular, ENT (ears, nose & throat), and therapeutic cell and drug delivery.

Harbin has a joint appointment in the College of Engineering and College of Veterinary Medicine at Purdue.

More information can be read on the GeniPhysWebsite.

Media are welcome to share, post and publish these stories, photos and videos.

Media contact: Steve Martin, SGMartin@prf.org

Research News

Arezoo Ardekani sits in an office and looks into the camera.

Purdue engineers test, validate novel method to improve pharmaceutical R&D

June 22, 2026

Researchers stand with mass spectrometry platform in lab.

Purdue researchers work to accelerate cancer drug discovery with next-gen tech platform

June 17, 2026

Researchers work with equipment in lab

Purdue Institute for Cancer Research secures $9.4M in renewal of its National Cancer Institute Cancer Center Support Grant

June 11, 2026

Researchers stand beside an open mass spectrometry system.

Faster chemical reactions made possible by tiny droplets

June 1, 2026